Epstein-Barr Virus-associated carcinoma

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

4 events
Jun 2026Pembrolizumab + MRGOO3 as Neoadjuvant in NPC

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology — PHASE2

TrialNOT YET RECRUITING
Mar 2025Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

University of California, San Francisco — NA

TrialRECRUITING
Jan 2025KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial

Kousai Bio Co., Ltd. — EARLY_PHASE1

TrialNOT YET RECRUITING
Jan 2022Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies

Stanford University — PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Epstein-Barr Virus-associated carcinoma.
Check the disease page for updates →

Clinical Trial Landscape

2 active trials
1Phase 2
1N/A
2Total recruiting
Search clinical trials for Epstein-Barr Virus-associated carcinoma

Recent News & Research

No recent news articles indexed yet for Epstein-Barr Virus-associated carcinoma.
Search PubMed for Epstein-Barr Virus-associated carcinoma

Browse all Epstein-Barr Virus-associated carcinoma news →

Specialist Network

Top 6 by expertise

View all Epstein-Barr Virus-associated carcinoma specialists →

Quick Actions